Hyperbaric oxygen therapy (HBO) has been used to promote healing of cutaneous ulcers secondary to diabetes mellitus, ionized radiation exposure injuries, gas gangrene, crush injuries, and necrotizing fasciitis. Despite the beneficial effects of HBO, there have been conflicting clinical experiences reported regarding its efficacy. To evaluate the effects of localized HBO, eight patients who were referred to a vascular surgery service with nonhealing rheumatoid vasculitic cutaneous ulcers were placed on a regional HBO regimen consisting of 100% fraction of inspired oxygen at 2 x atmospheric pressure for 60-90 minutes three times daily. Wound healing occurred in 87.5% of patients with a mean healing time of 4.7 weeks (range 2-10 weeks). The authors conclude that localized HBO for the treatment of refractory rheumatoid vasculitic ulcers is a safe and expedient modality to be considered and that these chronically hospitalized patients, exhausting other treatment regimens, may benefit from HBO therapy.
Get full access to this article
View all access options for this article.
References
1.
1. Marx RE, Johnson RP, and Kline SN: Prevention of osteoradionecrosis: A randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc111:48-54, 1985.
2.
2. Thomas CY, Crouch IA, Guastello J: Hyperbaric oxygen for pyoderma gangrenosum. Arch Dermatol110:445-446, 1974.
3.
3. Heng MCY: Hyperbaric oxygen for pyoderma gangrenosum. Aust N Z J Med14:618-621, 1984.
4.
4. Cianci P, Lueders HW, Lee H, et al: Adjunctive hyperbaric oxygen treatment reduces length of hospitalization in thermal burns. J Burn Care Rehab19:432-435, 1989.
5.
5. Nylander G, Lewis D, Nordstrom H, et al: Reduction of postoperative ischemic edema with hyperbaric oxygen. Plastic Reconstr Surg76:596-601, 1985.
6.
6. Schneider HA, Yonker RA, Katz P, et al: Rheumatoid vasculitis: Experience with 13 patients and review of the literature. Semin Arthritis Rheum14:280-286, 1985.
7.
7. Cawley MI: Vasculitis and ulceration in rheumatic diseases of the foot. Baillieres Clin Rheumatol1:315-333, 1987.
8.
8. Leslie CA, Saprico FL, et al: Randomized control trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care11:111-115, 1988.
9.
9. Marx RE, Johnson RP: Problem wounds in oral and maxillofacial surgery: The role of hyperbaric oxygen. In: Problem Wounds: The Role of Oxygen, ed. by Davis JC, Hunt TK. New York: Elsevier Science Publishing Co, 1988, pp 21-21.
10.
10. Hitchcock CR, Haglin JJ, Arnan O: Treatment of clostridial infections with hyperbaric oxygen. Surgery16:759-769, 1967.
11.
11. Hart GB, Lamb RC, Strauss MB: Gas gangrene: A collective review. J Trauma23:991-995, 1983.
12.
12. Bakker DL: Clostridial myonecrosis. In: Problem Wounds, ed. by Davis JC, Hunt TK. The Role of Oxygen. New York: Elsevier Science Publishing Co, 1988, pp 153-172.
13.
13. Perrins DJD, Maudsley RH, Colwill MR, et al: Hyperbaric oxygen in the management of chronic osteomyelitis. In: Proceedings of the Third International Conference on Hyperbaric Medicine, ed. by Brown IW, Cox BG. Washington, DC: National Academy of Science, National Research Council, publication 1404, 1966, pp 158-184.
14.
14. Riseman JA, Zamboni WA, Curtis A, et al: Hyperbaric oxygen for necrotizing fasciitis reduces mortality and the need for debridements. Surgery108:847-850, 1990.
15.
15. Hammarlund C, Sundberg T: Hyperbaric oxygen reduced size of chronic leg ulcers: A randomized double-blind study. Plastic Reconstr Surg93:829-834, 1994.
16.
16. Zhao LL, Davidson JD, Wee SC, et al: Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg129:1043-1049, 1994.
17.
17. Duff JH, Shibata HR, Vanschaik L, et al: Hyperbaric oxygen: A review of treatment in eighty-three patients. Can Med Assoc J97:510-515, 1967.
18.
18. Wattell F, Mathieu D, Coget JM, et al: Hyperbaric oxygen therapy in chronic vascular wound management. Angiology41:59-65, 1990.
19.
19. McCormick JN, Wojtacha D, Edmond E: Detection of cytomegalovirus antigens in phagocytosed serum complexes from a patient with rheumatoid arthritis, vasculitis, peripheral neuropathy, cutaneous ulcerations and digital gangrene. Ann Rheum Dis51:553-555, 1992.
20.
20. Vollertsen RS, Conn DL: Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am16:445-461, 1990.
22. Baker SR, Stacey MC, Singh G, et al: Aetiology of chronic leg ulcers. Eur J Vasc Surg6:245-251, 1992.
23.
23. Espinoza LR, Espinoza CG, Vasey FB, et al: Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J Am Acad Dermatol15:508-512, 1986.
24.
24. Winkelstein A, Starz TW, Agarwal A: Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis. J Rheumatol11:162-166, 1984.
25.
25. Kindwall EP: Uses of hyperbaric oxygen therapy in the 1990s. Cleve Clin J Med59:517-528, 1992.
26.
26. Lee HC, Niu KC, Chen SH, et al: Hyperbaric oxygen therapy in clinical application: A report of a 12-year experience. Chung Hua I Hsueh Tsa Chih43:307-316, 1989.
27.
27. Lindbom L, Tuma RF, Arfors KE: Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. Microvasc Res19:197-208, 1980.
28.
28. Leslie CA, Sapico FL, Ginunas VJ, et al: Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care11:111-115, 1988.
29.
29. Richmond MN, Galbraith KA, Rogerson JT: Hyperbaric oxygen for a thalassemic leg ulcer. J R Army Med Corps133:23-25, 1987.
